Prescription Medicines:

Euromoney Institutional Investor PLC
Newsletter  12 issues per annum

News, issues and strategies affecting the marketing of prescription and non-prescription drugs. It reports on pharmaceutical, biotechnology and drug-delivery companies, best-selling products, healthcare advertising agencies and executive compensation.

Med Ad News is the leading source of information on the business and marketing activities of the pharmaceutical industry. Published monthly in tabloid format, Med Ad News has become a standard throughout the pharmaceutical industry for its coverage of news, articles, special features and annual reports. Med Ad News is distributed to and read by more than 14,000 pharmaceutical professionals. It is the most respected and authoritative publication serving the pharmaceutical industry today.

Med Ad News is well known for its original and data-rich special reports that provide rankings and profiles of the leading health care advertising agencies, the leading biotechnology companies, the leading generic companies, drug delivery companies, new drug approvals, the world's best selling drugs, and the top 50 pharmaceutical companies.

Sample Contents
Vol. 20 No. 8 • August 2001
On the cover

Special feature— Brands without borders: Pharmaceutical companies are slowly putting the theory of global marketing into practice

Roche refocused: Rumors abound that Roche is a prime target for a takeover, but the Swiss company has taken several steps to strengthen its pharmaceutical division

Making room for Novo Nordisk: With a full portfolio of diabetes treatments, the Danish company is ready to become a fierce competitor in the United States

--------------------------------------------------------------------------------

Features

- New twist on switches: Managed care’s unprecedented move to force Allegra, Claritin, and Zyrtec
to over-the-counter status has physicians and manufacturers up in arms

- One shot at the top: With the launch of a unique diabetes product, Aventis may change the way
this disorder is being treated

- Axert joins the crowd: To elbow their way into the migraine market, Pharmacia marketers will
have to prove that Axert is better than rivals

- The last hurdle: The FDA nod is all that is needed for more than 190 medicines awaiting
marketing approval

Departments

- Marketing Roundup: News about products on the market
- Business Roundup: Covering business news
- People on the Move: Promotions, comings, and goings
- Adwise, Account Moves: Advertising agency news
- Webwatch: New Websites
- Media Beat: Media news
- Outsourcing Update: News about contract sales and marketing companies
- News from Rockville: Covering the FDA
- Drug Approvals: Approvals in the United States and the world

For full details, please email jenniferc@cmsinfo.com

Order Form

For more information about us, visit CMSinfo.